Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name ABBV-368
Trade Name
Synonyms ABBV368|ABBV 368
Drug Descriptions

ABBV-368 is an activating monoclonal antibody to the T-cell receptor, TNFRSF4 (OX40, CD134) (NCI Drug Dictionary).

DrugClasses OX40 Antibody 13
CAS Registry Number 2230138-89-1
NCIT ID C161864


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ABBV-368 ABBV-368 0 2
ABBV-368 + ABBV-927 ABBV-368 ABBV-927 0 1
ABBV-368 + ABBV-927 + Budigalimab ABBV-368 ABBV-927 Budigalimab 0 1
ABBV-368 + ABBV-927 + Carboplatin ABBV-368 ABBV-927 Carboplatin 0 1
ABBV-368 + ABBV-927 + Nab-paclitaxel ABBV-368 ABBV-927 Nab-paclitaxel 0 1
ABBV-368 + Budigalimab + IMO-2125 + Nab-paclitaxel ABBV-368 Budigalimab IMO-2125 Nab-paclitaxel 0 1
ABBV-368 + IMO-2125 ABBV-368 IMO-2125 0 1
ABBV-368 + IMO-2125 + Nab-paclitaxel ABBV-368 IMO-2125 Nab-paclitaxel 0 1
ABBV-368 + Nivolumab ABBV-368 Nivolumab 0 1

Additional content available in CKB BOOST